Display Settings:

Format

Send to:

Choose Destination
    Nature. 1990 Sep 13;347(6289):146-51.

    Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

    Source

    Unité de Neurobiologie et Pharmacologie (U. 109) de l'INSERM, Paris, France.

    Abstract

    A dopamine receptor has been characterized which differs in its pharmacology and signalling system from the D1 or D2 receptor and represents both an autoreceptor and a postsynaptic receptor. The D3 receptor is localized to limbic areas of the brain, which are associated with cognitive, emotional and endocrine functions. It seems to mediate some of the effects of antipsychotic drugs and drugs used against Parkinson's disease, that were previously thought to interact only with D2 receptors.

    PMID:
    1975644
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk